Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 937

1.

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.

Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; Coordinating Committee of the National Cholesterol Education Program.

Arterioscler Thromb Vasc Biol. 2004 Aug;24(8):e149-61. Review.

PMID:
15297292
[PubMed - indexed for MEDLINE]
Free Article
2.

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.

Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; Coordinating Committee of the National Cholesterol Education Program.

J Am Coll Cardiol. 2004 Aug 4;44(3):720-32. Review.

PMID:
15358046
[PubMed - indexed for MEDLINE]
Free Article
3.

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.

Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association.

Circulation. 2004 Jul 13;110(2):227-39. Review. Erratum in: Circulation. 2004 Aug 10;110(6):763.

PMID:
15249516
[PubMed - indexed for MEDLINE]
Free Article
4.

Recent National Cholesterol Education Program Adult Treatment Panel III update: adjustments and options.

Stone NJ, Bilek S, Rosenbaum S.

Am J Cardiol. 2005 Aug 22;96(4A):53E-59E. Review.

PMID:
16098845
[PubMed - indexed for MEDLINE]
5.

Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.

Evans M, Roberts A, Davies S, Rees A.

Drugs. 2004;64(11):1181-96. Review.

PMID:
15161326
[PubMed - indexed for MEDLINE]
6.

Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.

Cziraky MJ, Watson KE, Talbert RL.

J Manag Care Pharm. 2008 Oct;14(8 Suppl):S3-28; quiz S30-1. Review.

PMID:
19891279
[PubMed - indexed for MEDLINE]
Free Article
7.

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.

Cheng AY, Leiter LA.

Curr Opin Cardiol. 2006 Jul;21(4):400-4. Review.

PMID:
16755211
[PubMed - indexed for MEDLINE]
8.

Managing dyslipidemia in the high-risk patient.

Stein EA.

Am J Cardiol. 2002 Mar 7;89(5A):50C-57C. Review.

PMID:
11900720
[PubMed - indexed for MEDLINE]
9.

Treatment of high-risk older persons with lipid-lowering drug therapy.

Aronow WS.

Am J Ther. 2008 Mar-Apr;15(2):102-7. doi: 10.1097/MJT.0b013e31802b5aa4. Review.

PMID:
18356628
[PubMed - indexed for MEDLINE]
10.

Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe.

Daskalopoulou SS, Mikhailidis DP.

Curr Med Res Opin. 2006 Mar;22(3):511-28. Review.

PMID:
16574035
[PubMed - indexed for MEDLINE]
11.

An evidence-based assessment of the NCEP Adult Treatment Panel II guidelines. National Cholesterol Education Program.

Ansell BJ, Watson KE, Fogelman AM.

JAMA. 1999 Dec 1;282(21):2051-7. Review.

PMID:
10591388
[PubMed - indexed for MEDLINE]
12.

Update on the National Cholesterol Education Program Adult Treatment Panel III guidelines: getting to goal.

McKenney JM.

Pharmacotherapy. 2003 Sep;23(9 Pt 2):26S-33S. Review.

PMID:
14524636
[PubMed - indexed for MEDLINE]
13.

Perspectives on low-density lipoprotein cholesterol goal achievement.

Catapano AL.

Curr Med Res Opin. 2009 Feb;25(2):431-47. doi: 10.1185/03007990802631438 . Review.

PMID:
19192988
[PubMed - indexed for MEDLINE]
14.

Cardiovascular risk reduction: what do recent trials with rosuvastatin tell us?

Fabbri G, Maggioni AP.

Adv Ther. 2009 May;26(5):469-87. doi: 10.1007/s12325-009-0025-6. Epub 2009 May 14. Review.

PMID:
19444394
[PubMed - indexed for MEDLINE]
15.

Management of cardiovascular risk in patients with type 2 diabetes mellitus as a component of the cardiometabolic syndrome.

Ferdinand KC.

J Cardiometab Syndr. 2006 Spring;1(2):133-40. Review.

PMID:
17679832
[PubMed - indexed for MEDLINE]
16.

Cholesterol and atherosclerosis: a contemporary perspective.

Kashyap ML.

Ann Acad Med Singapore. 1997 Jul;26(4):517-23. Review.

PMID:
9395824
[PubMed - indexed for MEDLINE]
17.

[A new approach to the treatment of dyslipidemia].

Kevelaitiene S, Slapikas R.

Medicina (Kaunas). 2008;44(5):407-13. Review. Lithuanian.

PMID:
18541958
[PubMed - indexed for MEDLINE]
Free Article
18.

Combination therapy for combined dyslipidemia.

Xydakis AM, Ballantyne CM.

Am J Cardiol. 2002 Nov 20;90(10B):21K-29K. Review.

PMID:
12467937
[PubMed - indexed for MEDLINE]
19.

Management of hypercholesterolemia in older persons for the prevention of cardiovascular disease.

Aronow WS, Frishman WH.

Cardiol Rev. 2010 May-Jun;18(3):132-40. doi: 10.1097/CRD.0b013e3181c29571. Review.

PMID:
20395698
[PubMed - indexed for MEDLINE]
20.

Pharmacologic options for aggressive low-density lipoprotein cholesterol lowering: benefits versus risks.

McKenney JM.

Am J Cardiol. 2005 Aug 22;96(4A):60E-66E. Review.

PMID:
16098846
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk